• 제목/요약/키워드: Hepatectomy

검색결과 120건 처리시간 0.024초

Total robotic right hepatectomy for multifocal hepatocellular carcinoma using vessel sealer

  • Peeyush Varshney;Vaibhav Kumar Varshney
    • 한국간담췌외과학회지
    • /
    • 제27권1호
    • /
    • pp.95-101
    • /
    • 2023
  • Rapid adoption of a robotic approach as a minimally invasive surgery tool has enabled surgeons to perform more complex hepatobiliary surgeries than conventional laparoscopic surgery. Although various types of liver resections have been performed robotically, parenchymal transection is challenging as commonly used instruments (Cavitron Ultrasonic Surgical Aspirator [CUSA] and Harmonic) lack articulation. Further, CUSA also requires a patient-side assistant surgeon with hepatobiliary laparoscopic skills. We present a case report of total robotic right hepatectomy for multifocal hepatocellular carcinoma in a 70-year-old male using 'Vessel Sealer' for parenchymal transection. Total operative time was 520 minutes with a blood loss of ~400 mL. There was no technical difficulty or instrument failure encountered during surgery. The patient was discharged on postoperative day five without any significant complications such as bile leak. Thus, Vessel Sealer, a fully articulating instrument intended to seal vessels and tissues up to 7 mm, can be a promising tool for parenchymal transection in a robotic surgery.

Clinical Study of Hepatectomy Combined with Jianpi Huayu Therapy for Hepatocellular Carcinoma

  • Zhong, Chong;Li, Hui-Dong;Liu, Dong-Yang;Xu, Fa-Bin;Wu, Jian;Lin, Xue-Mei;Guo, Rong-Ping
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권14호
    • /
    • pp.5951-5957
    • /
    • 2014
  • Background: Traditional Chinese Medicine (TCM) possesses several advantages for treating patients with hepatocellular carcinoma (HCC). The theory of 'Jianpi Huayu Therapy' rooted from 'Jin Kui Yao Lue'is one of the most important therapies in this respect. This study was conducted to investigate the clinical effect and safety of hepatectomy combining with 'Jianpi Huayu Therapy' in the treatment of HCC. Materials and Methods: One hundred and twenty patients with HCC were randomized allocated into hepatectomy combined with 'Jianpi Huayu Therapy' group (treatment group, n=60) and hepatectomy alone group (control group, n=60). Disease- free survival (DFS) and overall survival (OS) were the primary end-points. Liver function at the end of one week after surgery, complications, average days of hospitalization as well as performance status (PS) at the end of one month post operation were also compared. Results: No significant differences existed between two groups on baseline analysis (p>0.05). No treatment related mortality occurred in either group. Post-operative complications were detected among 14 patients (23.3%) in the treatment group, and 12 (20.0%) in the control group (p=0.658). Alanine aminotransferase (ALT) at the end of one week after operation was lower in the treatment than control groups (p=0.042). No significant differences in other indexes of liver function were discovered between two groups. Average days of hospitalization reduced by 0.9 day in treatment group than in control (p=0.034). During follow-up, 104 patients (86.6%) developed recurrence. The rates of 1-, 3-, and 5-year DFS and median DFS for all patients were 77.4%, 26.3%, 9.0% and 25.6 months (range, 6.0~68.0), respectively (78.2%, 29.2%, 14.3% and 28.7 months for the 48 patients in the treatment group and 75.0%, 23.3%, 6.4%, and 22.6 months for the 56 patients in the control group (p=0.045)). 101 patients had died at the time of censor, with 1-, 3-, and 5-year overall survival rates and median survival for all patients of 97.5%, 76.4%, 40.5% and 51.2 months (range, 10.0~72.0), respectively (98.3%, 78.0%, 43.6% and 52.6 months, for treatment and 96.7%, 74.7%, 37.4%, and 49.8 months, for controls, respectively (p=0.048)). Conclusions: Hepatectomy combined with 'Jianpi Huayu therapy'was effective in the treatment of HCC, and reduced post-operative recurrence and metastasis and improved DFS and OS of HCC patients.

Genistein Reinforces the Inhibitory Effect of Cisplatin on Liver Cancer Recurrence and Metastasis after Curative Hepatectomy

  • Chen, Peng;Hu, Ming-Dao;Deng, Xiao-Fan;Li, Bo
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권2호
    • /
    • pp.759-764
    • /
    • 2013
  • Background: The high recurrence rate after hepatic resection in hepatocellular carcinoma (HCC) is a major obstacle to improving prognosis. The objective of the present study was to explore the function of genistein, a soy-derived isoflavone, in enhancing the inhibitory effect of cisplatin on HCC cell proliferation and on tumor recurrence and metastasis in nude mice after curative hepatectomy. Methods: Proliferation of human HCC cells (HCCLM3) was detected by 3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT) assay. Synergistic effects of genistein and cisplatin were evaluated with the median-effect formula. Nude mice bearing human HCC xenografts underwent tumour resection (hepatectomy) 10 days post implantation, then received intraperitoneal administration of genistein or cisplatin alone or the combination of the two drugs. 33 days after surgery, recurrent tumours and pulmonary metastasis were evaluated individually. MMP-2 level in recurrent tumours was detected by immunohistochemistry and real-time PCR; MMP-2 expression in HCCLM3 was detected by immunocytochemistry. Results: Genistein and cisplatin both suppressed the growth and proliferation of HCCLM3 cells. The two drugs exhibited synergistic effects even at relatively low concentrations. In vivo, mice in the combined genistein and cisplatin group had a smaller volume of liver recurrent tumors and fewer pulmonary metastatic foci compared with single drug treated groups. Cisplatin upregulated the expression of MMP-2 in both recurrent tumours and HCCLM3, while genistein abolished cisplatin-induced MMP-2 expression. Conclusions: Genistein reinforced the inhibitory effect of cisplatin on HCC cell proliferation and tumour recurrence and metastasis after curative hepatectomy in nude mice, possibly through mitigation of cisplatin-induced MMP-2 upregulation.

백서의 간세포막에서 Transferrin Receptor의 발현에 미치는 인삼의 영향 (Effect of Korean Ginseng on the Expression of Transferrin Receptor in the Liver Cell Membrane of Rat)

  • 임종호;홍장희;허강민;석정호;이재흔
    • Journal of Ginseng Research
    • /
    • 제23권2호
    • /
    • pp.105-114
    • /
    • 1999
  • 본 실험은 백서의 간세포막에서 transferrin receptor(TfR)의 발현에 미치는 인삼 및 3'-methyl-4-dimethylaminobenzene(3'-Me-DAB)의 영향을 연구하기 위하여, 인삼, 3'-Me-DAB 또는 3'-Me-DAB처치후 인삼을 투여한 백서를 부분 간절제한 후 간조직에서 $[^{3}H]thymidine$및 transferrin수용체의 유전자 발현 실험, 그리고 간세포막에서$[^{3}H]thymidine$ 결합 실험을 시행하여 다음과 같은 결과를 얻었다. 1. 8주간 3'-Me-DAB를 투여한 백서에서 간조직의 조직학적 소견은 림프구의 침윤, 담관세포의 증식,교량성괴사 및 이상세포의 증식 소견을 보였다. 그러나 정상 또는 3'-Me-DAB를 투여한 백서에 인삼을 투여하였을 때 간조직의 조직학적 소견은 각각의 대조군에 비해 크게 변화되지 않았다. 2. 인삼 또는 3'-Me-DAB를 투여한 백서에서의 $[^{3}H]thymidine$ uptake는 대조군에서와 비슷하였으나, 부분간절제 수술 후 1일째 간에서는 수술 전보다 현저하게 증가되었다. 특히 3'-Me-DAB투여군의 간조직에서 더 증가되었으며, 이는 인삼 투여에 의해 억제되는 경향을 보였다. 3. 간세포막에서의 transferrin 결합량(Bmax) 및 Kd는 정상 백서에서 각각 6.87pmole/mg protein 및 10.64nM이었으며, 인삼 투여에 의해 크게 변동되지 않았다 그러나 3'-Me-DAB를 투여한 백서에서는 Bmax 및 Kd가 증가되었고, 이 증가는 인삼투여에 의해 감소되었다. 부분 간절제 수술 후 간세포막에서의 Bmax 및 Kd는 모든 그룹에서 수술 후 3일째에는 증가, 수술 후 5일째에는 감소되는 양상을 나타냈다. 그러나 3'-Me-DAB투여 후 간절제 수술군에서의 증가가 가장 컸으며, 이 증가효과는 인삼 투여에 의하여 억제되었다. 4. 부문 간절제 수술 후 간조직에서의 TfR mRrfA 발현은 수술 후 24시간에 최대로 증가되었으며, 이는 3'-Me-DAB를 투여한 백서에서 더 현저하였다. 그리고 인삼은 3'-Me-DAB투여 후 간절제 수술군에서 증가된 발현양을 약간 감소시켰다. 이상의 결과로 백서에서 부분 간절제 수술 및 발암 물질에 의해 간세포막 transffirin수용체는 친화력이 저하된 TfR이 증가될 수 있으며, 이는 일부 이 수용체의유전자 수준에서 조절될 수 있는 것으로 생각된다. 그리고 인삼은 발암물질 투여등으로 간세포의 증식이 촉진되었을 때, 간세포내 핵산 합성 및 TfR mRNA 발현 조절을 통하여 세포막의 TfR출현 및 세포증식을 억제시킬 수 있을 것으로 추측된다.

  • PDF

Metallothionein Induction in Liver Regeneration Stimulated by Partial Hepatectomy

  • Kim, Wan-Jong;Shin, Kil-Sang
    • Animal cells and systems
    • /
    • 제5권3호
    • /
    • pp.263-266
    • /
    • 2001
  • Metallothionein (MT) is induced in the regenerating rat liver. We have investigated expression of MT gene by RT PCR as well as specific localization of MT by immunocytochemistry in regenerating rat liver after partial hepatectomy (PH). MT mRNA level started to increase from 1 h and reached the peak at 8 h after PH. The level decreased gradually by 24 h, and became similar to that of control group. In the immunocytochemical study, in all groups treated with primary antibody, immunogold particles indicating the presence of MT were evenly distributed throughout both cytoplasm and nucleus of the rat hepatocytes. Within the nucleus, the gold particles appeared to be intensely localized in the areas of euchromatin and nucleolus. Within the cytoplasm, gold particles did not seem to adhere to mitochondria or Iysosomes, but were freely distributed. However, rough endoplasmic reticulum was the obvious compartment on which the gold particles were localized. Time course of MT immunoreactivity revealed that distribution of gold particles in hepatocytes increased gradually by 24 h, and decreased at 48 h after PH. Briefly, PH resulted in the sharpest increase in the expression of MT mRNA at 8 h and in the immunoreactivity of MT at 24 h, respectively. It is suggested that the increase of MT mRNA expression, the intensity of immunoreactivity and the specific localization of MT may be associated with the compensatory cell proliferation followed by PH.

  • PDF

Changes of Nitric Oxide Synthase Activity and Free Methylarginines Contents in Regenerating Rat Liver after Partial Hepatectomy

  • Lee, Young-Jin;Nam, Suk-Woo;Seo, Dong-Wan;Ahn, Seong-Hoon;Ko, Young-Kwon;Sung, Dae-Suk;Han, Jeung-Whan;Hong, Sung-Youl;Lee, Hyang-Woo
    • Archives of Pharmacal Research
    • /
    • 제20권3호
    • /
    • pp.239-246
    • /
    • 1997
  • In the present study, liver regeneration rate (%) was increased up to 70% 3 days after partial hepatectomy (PH). Nitric oxide synthase (NOS) activity in liver tissue as well as serum nitrite/ nitrate content had no timed response, revealing no significant difference between shamoperated and partially hepatectomized rat liver. Contents of free methylarginines in liver tissue were increased biphasically in a time-dependent manner after PH. However, those in serum did not exhibit the same patterns as in liver. Taken together, the results suggest that $N^{G}$-monomethyl-L-arginine (MMA) and $ N^{G}, N^{G}$-dimethylarginine (DMA) play a role in inhibiting nitric oxide (NO) synthesis in regenerating rat liver because the increase of their contents was synchronized with NOS expression.

  • PDF

The Pringle maneuver in the modern era: A review of techniques for hepatic inflow occlusion in minimally invasive liver resection

  • Omar A. Mownah;Somaiah Aroori
    • 한국간담췌외과학회지
    • /
    • 제27권2호
    • /
    • pp.131-140
    • /
    • 2023
  • During minimally invasive liver resection (MILR), the Pringle maneuver aims to minimize blood loss and provide a clear operative field, thereby identifying intrahepatic structures and facilitating safe parenchymal transection. Several techniques for using the Pringle maneuver in MILR have been described. This review presents various methods which have been reported in the literature. A systematic literature search used the MEDLINE/PubMed database from its earliest records to August 2022 using appropriate search headings and keywords. The primary outcome was identifying techniques for performing hepatic inflow occlusion during laparoscopic/robotic hepatectomy. Inclusion criteria consisted of publications describing technical steps to obtain hepatic inflow occlusion during minimally invasive hepatectomy. A literature search identified 23 relevant publications, and the full texts were examined. The techniques described in the reports can be broadly categorized into three groups: (1) the Rummel-tourniquet technique, (2) vascular clamp use, and (3) the Huang Loop technique. Various techniques have been used in MILR to achieve inflow confinement successfully. The authors prefer the modified Huang Loop technique because it is inexpensive, reliable, and quick to apply or release. Hepatobiliary surgeons are advised to familiarize themselves with these MILR techniques, which have proven effective and safe inflow occlusion.

Is Hepatectomy for Huge Hepatocellular Carcinoma (≥10cm in Diameter) Safe and Effective? A Single-center Experience

  • Yang, Jian;Li, Chuan;Wen, Tian-Fu;Yan, Lu-Nan;Li, Bo;Wang, Wen-Tao;Yang, Jia-Yin;Xu, Ming-Qing
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권17호
    • /
    • pp.7069-7077
    • /
    • 2014
  • Background: This retrospective study aimed to validate the safety and effectiveness of hepatectomy for huge hepatocellular carcinoma (HCC). Materials and Methods: Data of patients who underwent hepatectomy for HCC between January 2006 and December 2012 were reviewed. The patients were divided into three groups: huge HCC(${\geq}10cm$ in diameter), large HCC(${\geq}5$ but<10 cm in diameter) and small HCC(<5cm in diameter). Results: Characteristics of pre-operative patients in all three groups were homogeneously distributed except for alpha fetal protein (AFP)(p<0.001).The 30, 60, 90-day post-operative mortality rates were not different among the three groups (p=0.785, p=0.560, and p=0.549). Laboratory data at 1, 3, and 7 days after surgery also did not vary. The 5-year overall survival (OS) and 5-year disease-free survival (DFS) rates in the huge and large HCC groups were lower than that of the small HCC group (OS: 32.5% vs 36.3% vs 71.2%, p=0.000; DFS: 20.0% vs 24.8% vs 40.7%, p=0.039), but there was no difference between the huge and large HCC groups (OS: 32.5% vs 36.3%, p=0.667; DFS: 20.0% vs 24.8%, p=0.540). In multivariate analysis, five independent poor prognostic factors that affected OS were significantly associated with worse survival (p<0.05), namely, AFP level, macrovascular invasion, Edmondsone Steiner grade, surgical margin and Ishak score. AFP level, macrovascular invasion, microvascular invasion, and surgical margin influenced disease-free survival independently (p<0.05). Conclusions: The safety of hepatectomy for huge HCC is similar to that for large and small HCC; and this approach for huge HCC may achieve similar long-term survival and disease-free survival as for large HCC.

Parenchymal-sparing anatomical hepatectomy based on portal ramification of the right anterior section: A prospective multicenter experience with short-term outcomes

  • Truong Giang Nguyen;Thanh Khiem Nguyen;Ham Hoi Nguyen;Hong Son Trinh;Tuan Hiep Luong;Minh Trong Nguyen;Van Duy Le;Hai Dang Do;Kieu Hung Nguyen;Van Minh Do;Quang Huy Tran;Cuong Thinh Nguyen
    • 한국간담췌외과학회지
    • /
    • 제28권1호
    • /
    • pp.25-33
    • /
    • 2024
  • Backgrounds/Aims: Parenchymal-sparing anatomical hepatectomy (Ps-AH) based on portal ramification of the right anterior section (RAS) is a new technique to avoid unnecessarily transecting too much liver parenchyma, especially in cases of major anatomical hepatectomy. Methods: We prospectively assessed 26 patients with primary hepatic malignancies having undergone major Ps-AH based on portal ramification of the RAS from August 2018 to August 2022 (48 months). The perioperative indications, clinical data, intra-operative index, pathological postoperative specimens, postoperative complications, and follow-up results were retrospectively evaluated. Results: Among the 26 patients analyzed, there was just one case that had intrahepatic cholangiocarcinoma The preoperative level of α-Fetoprotein was 25.2 ng/mL. All cases (100%) had Child-Pugh A liver function preoperatively. The ventral/dorsal RAS was preserved in 19 and 7 patients, respectively. The mean surgical margin was 6.2 mm. The mean surgical time was 228.5 minutes, while the mean blood loss was 255 mL. In pathology, 5 cases (19.2%) had microvascular invasion, and in the group of HCC patients, 92% of all cases had moderate or poor tumor differentiation. Six cases (23.1%) of postoperative complications were graded over III according to the Clavien-Dindo system, including in three patients resistant ascites or intra-abdominal abscess that required intervention. Conclusions: Parenchymal-sparing anatomical hepatectomy based on portal ramification of the RAS to achieve R0-resection was safe and effective, with favorable short-term outcomes. This technique can be used widely in clinical practice.

발암원과 부분간절제술 처리에 의한 백서 간 조직중 질소이용계 및 이물질 대사계 효소의 변화 (Effects of Carcinogens and Partial Hepatectomy on the Nitrogen Utilizing and the Xenobiotic Metabolizing Enzymes in the Hepatic Tissues of Rats)

  • 박상철;김응국;곽상준;이건욱;김수태
    • 한국환경성돌연변이발암원학회지
    • /
    • 제8권1호
    • /
    • pp.22-34
    • /
    • 1988
  • The biochemical changes of the hepatic tissues, induced by the carcinogen treatment such as diethylnitrosamine and acetamidofluorene in combination with the partial hepatectomy after Solt and Farber, were determined for the characterization of the induction of the proliferative capacity and the environmental adaptability of the carcinogenic tissues during the malignant transformation process. For the study of the proliferative capacity of the tissues, the activities of the enzymes, related with the nitrogen trapping mechanism, such as glutamine synthetase and gamma-glutamyltranspeptidase, were monitroed, while the cintents of cytochrome P450's and their isozymic patterns as well as the activities of the glutathione S-transferase were determined in the function of time after the hepatocarcinogenic stimuli.

  • PDF